Who owns KALA PHARMACEUTICALS INC?
- Ticker: KALA
- CUSIP Number: 483119202
Tip: Access positions for across all investors
Analyze quarterly positions in Kala Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kala Pharmaceuticals stock
Who bought or sold KALA PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| State Street Corporation | 29k | $4.9k | 0% | Mar 2026 |
|
| Morgan Stanley | 2.9k | $508.498900 | 385% | Mar 2026 |
|
Who sold out of Kala Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Renaissance Technologies | Mar 2026 | 418k | $72k |
| Citadel Advisors | Mar 2026 | 282k | $49k |
| Geode Capital Management | Mar 2026 | 261k | $45k |
| Virtu Financial | Mar 2026 | 152k | $26k |
| ADAR1 Capital Management | Mar 2026 | 142k | $25k |
| GSA Capital Partners | Mar 2026 | 85k | $15k |
| UBS Group | Mar 2026 | 67k | $12k |
| Vanguard Capital Management | Mar 2026 | 61k | $11k |
| Jane Street | Mar 2026 | 36k | $6.2k |
| Vanguard Fiduciary Trust | Mar 2026 | 30k | $5.1k |
| Grant Private Wealth Management | Mar 2026 | 20k | $3.5k |
| Greenwich Wealth Management | Mar 2026 | 18k | $3.0k |
| LPL Financial | Mar 2026 | 17k | $3.0k |
| Goldman Sachs Group | Mar 2026 | 14k | $2.4k |
| Intl Fcstone | Mar 2026 | 13k | $2.2k |
| Northern Trust | Mar 2026 | 12k | $2.0k |
| BlackRock | Mar 2026 | 11k | $1.9k |